| 注册
首页|期刊导航|中国临床药理学与治疗学|1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析

1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析

罗莉婷 金经

中国临床药理学与治疗学2024,Vol.29Issue(5):495-500,6.
中国临床药理学与治疗学2024,Vol.29Issue(5):495-500,6.DOI:10.12092/j.issn.1009-2501.2024.05.003

1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析

A case analysis of medication adjustments on a moyamoya disease patient with endometriosis by DAPT treatment during perioperative period and formulation of DIE postoperative recurrence prevention

罗莉婷 1金经2

作者信息

  • 1. 复旦大学附属妇产科医院药学部,上海 200090||珠海市妇幼保健院药学部,珠海 519000,广东
  • 2. 复旦大学附属妇产科医院药学部,上海 200090
  • 折叠

摘要

Abstract

AIM:To explore the key points of per-sonalized treatment and medication monitoring by clinical pharmacists in the perioperative period of moyamoya disease patients with endometriosis.METHODS:This study showed a moyamoya disease patient with endometriosis who accepting dual an-tiplatelet therapy and how to adjust medication during the perioperative period.Besides,monitor-ing the use proton pump inhibitors in the perioper-ative period and the formulating a plan of DIE post-operative recurrence prevention are also our objec-tives.RESULTS:Through individualized assessment of the patient,a personalized medication adjust-ments for dual antiplatelet therapy was deter-mined.Individualized perioperative proton pump inhibitor regimen and postoperative prevention plan for endometriosis recurrence were developed.CONCLUSION:The development of individualized medication regimens and medication monitoring is the breakthrough point for clinical pharmacists to carry out pharmaceutical services.

关键词

烟雾病/子宫内膜异位症/双联抗血小板/预防复发

Key words

moyamoya disease/endometriosis/DAPT/preventing recurrence

分类

医药卫生

引用本文复制引用

罗莉婷,金经..1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析[J].中国临床药理学与治疗学,2024,29(5):495-500,6.

基金项目

2021年上海市"医苑新星"青年医学人才培养资助(076478684Q/2022-00033) (076478684Q/2022-00033)

中国临床药理学与治疗学

OA北大核心CSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文